nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—Body temperature increased—Chlorambucil—ovarian cancer	0.00327	0.00327	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00326	0.00326	CcSEcCtD
Zanamivir—Discomfort—Vinorelbine—ovarian cancer	0.00325	0.00325	CcSEcCtD
Zanamivir—Dyspnoea—Melphalan—ovarian cancer	0.00321	0.00321	CcSEcCtD
Zanamivir—Decreased appetite—Topotecan—ovarian cancer	0.0032	0.0032	CcSEcCtD
Zanamivir—Musculoskeletal pain—Doxorubicin—ovarian cancer	0.00318	0.00318	CcSEcCtD
Zanamivir—Fatigue—Topotecan—ovarian cancer	0.00317	0.00317	CcSEcCtD
Zanamivir—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00315	0.00315	CcSEcCtD
Zanamivir—Pain—Topotecan—ovarian cancer	0.00315	0.00315	CcSEcCtD
Zanamivir—Decreased appetite—Melphalan—ovarian cancer	0.00313	0.00313	CcSEcCtD
Zanamivir—Infection—Vinorelbine—ovarian cancer	0.00313	0.00313	CcSEcCtD
Zanamivir—Sinusitis—Paclitaxel—ovarian cancer	0.00312	0.00312	CcSEcCtD
Zanamivir—Fatigue—Melphalan—ovarian cancer	0.00311	0.00311	CcSEcCtD
Zanamivir—Bronchospasm—Docetaxel—ovarian cancer	0.0031	0.0031	CcSEcCtD
Zanamivir—Pain—Melphalan—ovarian cancer	0.00308	0.00308	CcSEcCtD
Zanamivir—Skin disorder—Vinorelbine—ovarian cancer	0.00306	0.00306	CcSEcCtD
Zanamivir—Influenza like illness—Doxorubicin—ovarian cancer	0.00305	0.00305	CcSEcCtD
Zanamivir—Hypersensitivity—Chlorambucil—ovarian cancer	0.00305	0.00305	CcSEcCtD
Zanamivir—Feeling abnormal—Topotecan—ovarian cancer	0.00303	0.00303	CcSEcCtD
Zanamivir—Gastrointestinal pain—Topotecan—ovarian cancer	0.00301	0.00301	CcSEcCtD
Zanamivir—Anorexia—Vinorelbine—ovarian cancer	0.003	0.003	CcSEcCtD
Zanamivir—Haemoglobin—Paclitaxel—ovarian cancer	0.003	0.003	CcSEcCtD
Zanamivir—Haemorrhage—Paclitaxel—ovarian cancer	0.00298	0.00298	CcSEcCtD
Zanamivir—Asthenia—Chlorambucil—ovarian cancer	0.00297	0.00297	CcSEcCtD
Zanamivir—Neutropenia—Docetaxel—ovarian cancer	0.00295	0.00295	CcSEcCtD
Zanamivir—Urticaria—Topotecan—ovarian cancer	0.00292	0.00292	CcSEcCtD
Zanamivir—Body temperature increased—Topotecan—ovarian cancer	0.00291	0.00291	CcSEcCtD
Zanamivir—Abdominal pain—Topotecan—ovarian cancer	0.00291	0.00291	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00287	0.00287	CcSEcCtD
Zanamivir—Urticaria—Melphalan—ovarian cancer	0.00286	0.00286	CcSEcCtD
Zanamivir—Diarrhoea—Chlorambucil—ovarian cancer	0.00283	0.00283	CcSEcCtD
Zanamivir—Erythema multiforme—Paclitaxel—ovarian cancer	0.00282	0.00282	CcSEcCtD
Zanamivir—Dyspnoea—Vinorelbine—ovarian cancer	0.00281	0.00281	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00279	0.00279	CcSEcCtD
Zanamivir—Decreased appetite—Vinorelbine—ovarian cancer	0.00274	0.00274	CcSEcCtD
Zanamivir—Fatigue—Vinorelbine—ovarian cancer	0.00271	0.00271	CcSEcCtD
Zanamivir—Hypersensitivity—Topotecan—ovarian cancer	0.00271	0.00271	CcSEcCtD
Zanamivir—Pain—Vinorelbine—ovarian cancer	0.00269	0.00269	CcSEcCtD
Zanamivir—Chills—Paclitaxel—ovarian cancer	0.00267	0.00267	CcSEcCtD
Zanamivir—Arrhythmia—Paclitaxel—ovarian cancer	0.00266	0.00266	CcSEcCtD
Zanamivir—Hypersensitivity—Melphalan—ovarian cancer	0.00266	0.00266	CcSEcCtD
Zanamivir—Asthenia—Topotecan—ovarian cancer	0.00264	0.00264	CcSEcCtD
Zanamivir—Vomiting—Chlorambucil—ovarian cancer	0.00263	0.00263	CcSEcCtD
Zanamivir—Increased appetite—Epirubicin—ovarian cancer	0.00262	0.00262	CcSEcCtD
Zanamivir—Feeling abnormal—Vinorelbine—ovarian cancer	0.00259	0.00259	CcSEcCtD
Zanamivir—Asthenia—Melphalan—ovarian cancer	0.00259	0.00259	CcSEcCtD
Zanamivir—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00257	0.00257	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00255	0.00255	CcSEcCtD
Zanamivir—Haemoglobin—Docetaxel—ovarian cancer	0.00254	0.00254	CcSEcCtD
Zanamivir—Haemorrhage—Docetaxel—ovarian cancer	0.00253	0.00253	CcSEcCtD
Zanamivir—Diarrhoea—Topotecan—ovarian cancer	0.00252	0.00252	CcSEcCtD
Zanamivir—Urticaria—Vinorelbine—ovarian cancer	0.0025	0.0025	CcSEcCtD
Zanamivir—Abdominal pain—Vinorelbine—ovarian cancer	0.00249	0.00249	CcSEcCtD
Zanamivir—Body temperature increased—Vinorelbine—ovarian cancer	0.00249	0.00249	CcSEcCtD
Zanamivir—Diarrhoea—Melphalan—ovarian cancer	0.00247	0.00247	CcSEcCtD
Zanamivir—Nausea—Chlorambucil—ovarian cancer	0.00246	0.00246	CcSEcCtD
Zanamivir—Dizziness—Topotecan—ovarian cancer	0.00243	0.00243	CcSEcCtD
Zanamivir—Increased appetite—Doxorubicin—ovarian cancer	0.00243	0.00243	CcSEcCtD
Zanamivir—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00241	0.00241	CcSEcCtD
Zanamivir—Erythema multiforme—Docetaxel—ovarian cancer	0.00239	0.00239	CcSEcCtD
Zanamivir—Agitation—Paclitaxel—ovarian cancer	0.00238	0.00238	CcSEcCtD
Zanamivir—Face oedema—Epirubicin—ovarian cancer	0.00238	0.00238	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00235	0.00235	CcSEcCtD
Zanamivir—Vomiting—Topotecan—ovarian cancer	0.00234	0.00234	CcSEcCtD
Zanamivir—Malaise—Paclitaxel—ovarian cancer	0.00234	0.00234	CcSEcCtD
Zanamivir—Syncope—Paclitaxel—ovarian cancer	0.00233	0.00233	CcSEcCtD
Zanamivir—Rash—Topotecan—ovarian cancer	0.00232	0.00232	CcSEcCtD
Zanamivir—Hypersensitivity—Vinorelbine—ovarian cancer	0.00232	0.00232	CcSEcCtD
Zanamivir—Dermatitis—Topotecan—ovarian cancer	0.00232	0.00232	CcSEcCtD
Zanamivir—Headache—Topotecan—ovarian cancer	0.00231	0.00231	CcSEcCtD
Zanamivir—Vomiting—Melphalan—ovarian cancer	0.00229	0.00229	CcSEcCtD
Zanamivir—Dehydration—Epirubicin—ovarian cancer	0.00229	0.00229	CcSEcCtD
Zanamivir—Loss of consciousness—Paclitaxel—ovarian cancer	0.00228	0.00228	CcSEcCtD
Zanamivir—Rash—Melphalan—ovarian cancer	0.00227	0.00227	CcSEcCtD
Zanamivir—Dermatitis—Melphalan—ovarian cancer	0.00227	0.00227	CcSEcCtD
Zanamivir—Chills—Docetaxel—ovarian cancer	0.00227	0.00227	CcSEcCtD
Zanamivir—Cough—Paclitaxel—ovarian cancer	0.00226	0.00226	CcSEcCtD
Zanamivir—Asthenia—Vinorelbine—ovarian cancer	0.00226	0.00226	CcSEcCtD
Zanamivir—Arrhythmia—Docetaxel—ovarian cancer	0.00226	0.00226	CcSEcCtD
Zanamivir—Convulsion—Paclitaxel—ovarian cancer	0.00225	0.00225	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00222	0.00222	CcSEcCtD
Zanamivir—Arthralgia—Paclitaxel—ovarian cancer	0.00221	0.00221	CcSEcCtD
Zanamivir—Myalgia—Paclitaxel—ovarian cancer	0.00221	0.00221	CcSEcCtD
Zanamivir—Anxiety—Paclitaxel—ovarian cancer	0.0022	0.0022	CcSEcCtD
Zanamivir—Face oedema—Doxorubicin—ovarian cancer	0.0022	0.0022	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00219	0.00219	CcSEcCtD
Zanamivir—Nausea—Topotecan—ovarian cancer	0.00219	0.00219	CcSEcCtD
Zanamivir—Discomfort—Paclitaxel—ovarian cancer	0.00218	0.00218	CcSEcCtD
Zanamivir—Diarrhoea—Vinorelbine—ovarian cancer	0.00215	0.00215	CcSEcCtD
Zanamivir—Nausea—Melphalan—ovarian cancer	0.00214	0.00214	CcSEcCtD
Zanamivir—Confusional state—Paclitaxel—ovarian cancer	0.00214	0.00214	CcSEcCtD
Zanamivir—Influenza—Epirubicin—ovarian cancer	0.00213	0.00213	CcSEcCtD
Zanamivir—Asthma—Epirubicin—ovarian cancer	0.00213	0.00213	CcSEcCtD
Zanamivir—Dehydration—Doxorubicin—ovarian cancer	0.00212	0.00212	CcSEcCtD
Zanamivir—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00212	0.00212	CcSEcCtD
Zanamivir—Infection—Paclitaxel—ovarian cancer	0.0021	0.0021	CcSEcCtD
Zanamivir—Shock—Paclitaxel—ovarian cancer	0.00208	0.00208	CcSEcCtD
Zanamivir—Dizziness—Vinorelbine—ovarian cancer	0.00208	0.00208	CcSEcCtD
Zanamivir—Skin disorder—Paclitaxel—ovarian cancer	0.00206	0.00206	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00205	0.00205	CcSEcCtD
Zanamivir—Bronchitis—Epirubicin—ovarian cancer	0.00205	0.00205	CcSEcCtD
Zanamivir—Anorexia—Paclitaxel—ovarian cancer	0.00202	0.00202	CcSEcCtD
Zanamivir—Vomiting—Vinorelbine—ovarian cancer	0.002	0.002	CcSEcCtD
Zanamivir—Neutropenia—Epirubicin—ovarian cancer	0.00199	0.00199	CcSEcCtD
Zanamivir—Rash—Vinorelbine—ovarian cancer	0.00199	0.00199	CcSEcCtD
Zanamivir—Dermatitis—Vinorelbine—ovarian cancer	0.00198	0.00198	CcSEcCtD
Zanamivir—Headache—Vinorelbine—ovarian cancer	0.00197	0.00197	CcSEcCtD
Zanamivir—Syncope—Docetaxel—ovarian cancer	0.00197	0.00197	CcSEcCtD
Zanamivir—Influenza—Doxorubicin—ovarian cancer	0.00197	0.00197	CcSEcCtD
Zanamivir—Asthma—Doxorubicin—ovarian cancer	0.00197	0.00197	CcSEcCtD
Zanamivir—Loss of consciousness—Docetaxel—ovarian cancer	0.00193	0.00193	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00193	0.00193	CcSEcCtD
Zanamivir—Cough—Docetaxel—ovarian cancer	0.00192	0.00192	CcSEcCtD
Zanamivir—Convulsion—Docetaxel—ovarian cancer	0.00191	0.00191	CcSEcCtD
Zanamivir—Bronchitis—Doxorubicin—ovarian cancer	0.00189	0.00189	CcSEcCtD
Zanamivir—Dyspnoea—Paclitaxel—ovarian cancer	0.00189	0.00189	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00188	0.00188	CcSEcCtD
Zanamivir—Myalgia—Docetaxel—ovarian cancer	0.00187	0.00187	CcSEcCtD
Zanamivir—Arthralgia—Docetaxel—ovarian cancer	0.00187	0.00187	CcSEcCtD
Zanamivir—Nausea—Vinorelbine—ovarian cancer	0.00187	0.00187	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00186	0.00186	CcSEcCtD
Zanamivir—Neutropenia—Doxorubicin—ovarian cancer	0.00184	0.00184	CcSEcCtD
Zanamivir—Decreased appetite—Paclitaxel—ovarian cancer	0.00184	0.00184	CcSEcCtD
Zanamivir—Fatigue—Paclitaxel—ovarian cancer	0.00183	0.00183	CcSEcCtD
Zanamivir—Pain—Paclitaxel—ovarian cancer	0.00181	0.00181	CcSEcCtD
Zanamivir—Confusional state—Docetaxel—ovarian cancer	0.00181	0.00181	CcSEcCtD
Zanamivir—Anaphylactic shock—Docetaxel—ovarian cancer	0.0018	0.0018	CcSEcCtD
Zanamivir—Infection—Docetaxel—ovarian cancer	0.00178	0.00178	CcSEcCtD
Zanamivir—Sinusitis—Epirubicin—ovarian cancer	0.00178	0.00178	CcSEcCtD
Zanamivir—Shock—Docetaxel—ovarian cancer	0.00177	0.00177	CcSEcCtD
Zanamivir—Feeling abnormal—Paclitaxel—ovarian cancer	0.00175	0.00175	CcSEcCtD
Zanamivir—Skin disorder—Docetaxel—ovarian cancer	0.00174	0.00174	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00174	0.00174	CcSEcCtD
Zanamivir—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00173	0.00173	CcSEcCtD
Zanamivir—Haemoglobin—Epirubicin—ovarian cancer	0.00171	0.00171	CcSEcCtD
Zanamivir—Anorexia—Docetaxel—ovarian cancer	0.00171	0.00171	CcSEcCtD
Zanamivir—Haemorrhage—Epirubicin—ovarian cancer	0.0017	0.0017	CcSEcCtD
Zanamivir—Urticaria—Paclitaxel—ovarian cancer	0.00168	0.00168	CcSEcCtD
Zanamivir—Body temperature increased—Paclitaxel—ovarian cancer	0.00167	0.00167	CcSEcCtD
Zanamivir—Abdominal pain—Paclitaxel—ovarian cancer	0.00167	0.00167	CcSEcCtD
Zanamivir—Sinusitis—Doxorubicin—ovarian cancer	0.00165	0.00165	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00164	0.00164	CcSEcCtD
Zanamivir—Erythema multiforme—Epirubicin—ovarian cancer	0.00161	0.00161	CcSEcCtD
Zanamivir—Dyspnoea—Docetaxel—ovarian cancer	0.0016	0.0016	CcSEcCtD
Zanamivir—Haemoglobin—Doxorubicin—ovarian cancer	0.00158	0.00158	CcSEcCtD
Zanamivir—Haemorrhage—Doxorubicin—ovarian cancer	0.00158	0.00158	CcSEcCtD
Zanamivir—Decreased appetite—Docetaxel—ovarian cancer	0.00156	0.00156	CcSEcCtD
Zanamivir—Hypersensitivity—Paclitaxel—ovarian cancer	0.00156	0.00156	CcSEcCtD
Zanamivir—Fatigue—Docetaxel—ovarian cancer	0.00155	0.00155	CcSEcCtD
Zanamivir—Pain—Docetaxel—ovarian cancer	0.00154	0.00154	CcSEcCtD
Zanamivir—Chills—Epirubicin—ovarian cancer	0.00153	0.00153	CcSEcCtD
Zanamivir—Arrhythmia—Epirubicin—ovarian cancer	0.00152	0.00152	CcSEcCtD
Zanamivir—Asthenia—Paclitaxel—ovarian cancer	0.00152	0.00152	CcSEcCtD
Zanamivir—Erythema multiforme—Doxorubicin—ovarian cancer	0.00149	0.00149	CcSEcCtD
Zanamivir—Feeling abnormal—Docetaxel—ovarian cancer	0.00148	0.00148	CcSEcCtD
Zanamivir—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00147	0.00147	CcSEcCtD
Zanamivir—Diarrhoea—Paclitaxel—ovarian cancer	0.00145	0.00145	CcSEcCtD
Zanamivir—Abdominal pain—Docetaxel—ovarian cancer	0.00142	0.00142	CcSEcCtD
Zanamivir—Body temperature increased—Docetaxel—ovarian cancer	0.00142	0.00142	CcSEcCtD
Zanamivir—Chills—Doxorubicin—ovarian cancer	0.00141	0.00141	CcSEcCtD
Zanamivir—Arrhythmia—Doxorubicin—ovarian cancer	0.00141	0.00141	CcSEcCtD
Zanamivir—Dizziness—Paclitaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Zanamivir—Ill-defined disorder—Epirubicin—ovarian cancer	0.00138	0.00138	CcSEcCtD
Zanamivir—Agitation—Epirubicin—ovarian cancer	0.00136	0.00136	CcSEcCtD
Zanamivir—Vomiting—Paclitaxel—ovarian cancer	0.00135	0.00135	CcSEcCtD
Zanamivir—Malaise—Epirubicin—ovarian cancer	0.00134	0.00134	CcSEcCtD
Zanamivir—Rash—Paclitaxel—ovarian cancer	0.00134	0.00134	CcSEcCtD
Zanamivir—Dermatitis—Paclitaxel—ovarian cancer	0.00133	0.00133	CcSEcCtD
Zanamivir—Syncope—Epirubicin—ovarian cancer	0.00133	0.00133	CcSEcCtD
Zanamivir—Headache—Paclitaxel—ovarian cancer	0.00133	0.00133	CcSEcCtD
Zanamivir—Hypersensitivity—Docetaxel—ovarian cancer	0.00132	0.00132	CcSEcCtD
Zanamivir—Loss of consciousness—Epirubicin—ovarian cancer	0.0013	0.0013	CcSEcCtD
Zanamivir—Cough—Epirubicin—ovarian cancer	0.00129	0.00129	CcSEcCtD
Zanamivir—Asthenia—Docetaxel—ovarian cancer	0.00129	0.00129	CcSEcCtD
Zanamivir—Convulsion—Epirubicin—ovarian cancer	0.00129	0.00129	CcSEcCtD
Zanamivir—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00127	0.00127	CcSEcCtD
Zanamivir—Myalgia—Epirubicin—ovarian cancer	0.00126	0.00126	CcSEcCtD
Zanamivir—Arthralgia—Epirubicin—ovarian cancer	0.00126	0.00126	CcSEcCtD
Zanamivir—Agitation—Doxorubicin—ovarian cancer	0.00126	0.00126	CcSEcCtD
Zanamivir—Anxiety—Epirubicin—ovarian cancer	0.00126	0.00126	CcSEcCtD
Zanamivir—Nausea—Paclitaxel—ovarian cancer	0.00126	0.00126	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00125	0.00125	CcSEcCtD
Zanamivir—Discomfort—Epirubicin—ovarian cancer	0.00125	0.00125	CcSEcCtD
Zanamivir—Malaise—Doxorubicin—ovarian cancer	0.00124	0.00124	CcSEcCtD
Zanamivir—Syncope—Doxorubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
Zanamivir—Diarrhoea—Docetaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Zanamivir—Confusional state—Epirubicin—ovarian cancer	0.00122	0.00122	CcSEcCtD
Zanamivir—Anaphylactic shock—Epirubicin—ovarian cancer	0.00121	0.00121	CcSEcCtD
Zanamivir—Loss of consciousness—Doxorubicin—ovarian cancer	0.00121	0.00121	CcSEcCtD
Zanamivir—Infection—Epirubicin—ovarian cancer	0.0012	0.0012	CcSEcCtD
Zanamivir—Cough—Doxorubicin—ovarian cancer	0.0012	0.0012	CcSEcCtD
Zanamivir—Shock—Epirubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Zanamivir—Convulsion—Doxorubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Zanamivir—Dizziness—Docetaxel—ovarian cancer	0.00119	0.00119	CcSEcCtD
Zanamivir—Skin disorder—Epirubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Zanamivir—Arthralgia—Doxorubicin—ovarian cancer	0.00117	0.00117	CcSEcCtD
Zanamivir—Myalgia—Doxorubicin—ovarian cancer	0.00117	0.00117	CcSEcCtD
Zanamivir—Anxiety—Doxorubicin—ovarian cancer	0.00116	0.00116	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00116	0.00116	CcSEcCtD
Zanamivir—Discomfort—Doxorubicin—ovarian cancer	0.00115	0.00115	CcSEcCtD
Zanamivir—Anorexia—Epirubicin—ovarian cancer	0.00115	0.00115	CcSEcCtD
Zanamivir—Vomiting—Docetaxel—ovarian cancer	0.00114	0.00114	CcSEcCtD
Zanamivir—Rash—Docetaxel—ovarian cancer	0.00113	0.00113	CcSEcCtD
Zanamivir—Dermatitis—Docetaxel—ovarian cancer	0.00113	0.00113	CcSEcCtD
Zanamivir—Confusional state—Doxorubicin—ovarian cancer	0.00113	0.00113	CcSEcCtD
Zanamivir—Headache—Docetaxel—ovarian cancer	0.00112	0.00112	CcSEcCtD
Zanamivir—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00112	0.00112	CcSEcCtD
Zanamivir—Infection—Doxorubicin—ovarian cancer	0.00111	0.00111	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Zanamivir—Shock—Doxorubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Zanamivir—Skin disorder—Doxorubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Zanamivir—Dyspnoea—Epirubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Zanamivir—Anorexia—Doxorubicin—ovarian cancer	0.00107	0.00107	CcSEcCtD
Zanamivir—Nausea—Docetaxel—ovarian cancer	0.00107	0.00107	CcSEcCtD
Zanamivir—Decreased appetite—Epirubicin—ovarian cancer	0.00105	0.00105	CcSEcCtD
Zanamivir—Fatigue—Epirubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Zanamivir—Pain—Epirubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Zanamivir—Dyspnoea—Doxorubicin—ovarian cancer	0.000999	0.000999	CcSEcCtD
Zanamivir—Feeling abnormal—Epirubicin—ovarian cancer	0.000998	0.000998	CcSEcCtD
Zanamivir—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00099	0.00099	CcSEcCtD
Zanamivir—Decreased appetite—Doxorubicin—ovarian cancer	0.000974	0.000974	CcSEcCtD
Zanamivir—Fatigue—Doxorubicin—ovarian cancer	0.000966	0.000966	CcSEcCtD
Zanamivir—Urticaria—Epirubicin—ovarian cancer	0.000962	0.000962	CcSEcCtD
Zanamivir—Pain—Doxorubicin—ovarian cancer	0.000958	0.000958	CcSEcCtD
Zanamivir—Abdominal pain—Epirubicin—ovarian cancer	0.000957	0.000957	CcSEcCtD
Zanamivir—Body temperature increased—Epirubicin—ovarian cancer	0.000957	0.000957	CcSEcCtD
Zanamivir—Feeling abnormal—Doxorubicin—ovarian cancer	0.000923	0.000923	CcSEcCtD
Zanamivir—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000916	0.000916	CcSEcCtD
Zanamivir—Hypersensitivity—Epirubicin—ovarian cancer	0.000892	0.000892	CcSEcCtD
Zanamivir—Urticaria—Doxorubicin—ovarian cancer	0.00089	0.00089	CcSEcCtD
Zanamivir—Abdominal pain—Doxorubicin—ovarian cancer	0.000886	0.000886	CcSEcCtD
Zanamivir—Body temperature increased—Doxorubicin—ovarian cancer	0.000886	0.000886	CcSEcCtD
Zanamivir—Asthenia—Epirubicin—ovarian cancer	0.000869	0.000869	CcSEcCtD
Zanamivir—Diarrhoea—Epirubicin—ovarian cancer	0.000828	0.000828	CcSEcCtD
Zanamivir—Hypersensitivity—Doxorubicin—ovarian cancer	0.000825	0.000825	CcSEcCtD
Zanamivir—Asthenia—Doxorubicin—ovarian cancer	0.000804	0.000804	CcSEcCtD
Zanamivir—Dizziness—Epirubicin—ovarian cancer	0.000801	0.000801	CcSEcCtD
Zanamivir—Vomiting—Epirubicin—ovarian cancer	0.00077	0.00077	CcSEcCtD
Zanamivir—Diarrhoea—Doxorubicin—ovarian cancer	0.000766	0.000766	CcSEcCtD
Zanamivir—Rash—Epirubicin—ovarian cancer	0.000763	0.000763	CcSEcCtD
Zanamivir—Dermatitis—Epirubicin—ovarian cancer	0.000763	0.000763	CcSEcCtD
Zanamivir—Headache—Epirubicin—ovarian cancer	0.000758	0.000758	CcSEcCtD
Zanamivir—Dizziness—Doxorubicin—ovarian cancer	0.000741	0.000741	CcSEcCtD
Zanamivir—Nausea—Epirubicin—ovarian cancer	0.000719	0.000719	CcSEcCtD
Zanamivir—Vomiting—Doxorubicin—ovarian cancer	0.000712	0.000712	CcSEcCtD
Zanamivir—Rash—Doxorubicin—ovarian cancer	0.000706	0.000706	CcSEcCtD
Zanamivir—Dermatitis—Doxorubicin—ovarian cancer	0.000706	0.000706	CcSEcCtD
Zanamivir—Headache—Doxorubicin—ovarian cancer	0.000702	0.000702	CcSEcCtD
Zanamivir—Nausea—Doxorubicin—ovarian cancer	0.000665	0.000665	CcSEcCtD
